NO20062358L - Combinations for the treatment of proliferative diseases - Google Patents
Combinations for the treatment of proliferative diseasesInfo
- Publication number
- NO20062358L NO20062358L NO20062358A NO20062358A NO20062358L NO 20062358 L NO20062358 L NO 20062358L NO 20062358 A NO20062358 A NO 20062358A NO 20062358 A NO20062358 A NO 20062358A NO 20062358 L NO20062358 L NO 20062358L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- proliferative diseases
- combinations
- cancer
- drugs
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Det beskrives kombinasjoner av medikamenter til behandlingen av proliferative sykdommer (f.eks. cancer). Det beskrives også fremgangsmåter for identifisering av nye kombinasjonsterapier til behandlingen av cancer og andre proliferative sykdommer.Combinations of drugs are described for the treatment of proliferative diseases (eg cancer). Methods are also described for identifying novel combination therapies for the treatment of cancer and other proliferative diseases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51955103P | 2003-11-12 | 2003-11-12 | |
US10/855,130 US20050100508A1 (en) | 2003-11-12 | 2004-05-27 | Methods for identifying drug combinations for the treatment of proliferative diseases |
PCT/US2004/037527 WO2005046607A2 (en) | 2003-11-12 | 2004-11-09 | Combinations for the treatment of proliferative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062358L true NO20062358L (en) | 2006-07-12 |
Family
ID=34556562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062358A NO20062358L (en) | 2003-11-12 | 2006-05-23 | Combinations for the treatment of proliferative diseases |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1689352A2 (en) |
JP (1) | JP2007524657A (en) |
KR (1) | KR20060118514A (en) |
AR (1) | AR046841A1 (en) |
AU (1) | AU2004289311A1 (en) |
BR (1) | BRPI0416390A (en) |
CA (1) | CA2545423A1 (en) |
IL (1) | IL175611A0 (en) |
IS (1) | IS8496A (en) |
NO (1) | NO20062358L (en) |
RU (1) | RU2006120491A (en) |
TW (1) | TW200526777A (en) |
WO (1) | WO2005046607A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8663643B2 (en) * | 2008-03-18 | 2014-03-04 | Genentech, Inc. | Combinations of an anti-HER2 antibody-drug conjugate and chemotherapeutic agents, and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2235420A1 (en) * | 1998-06-17 | 1999-12-17 | Paolo Renzi | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
-
2004
- 2004-11-05 TW TW093133826A patent/TW200526777A/en unknown
- 2004-11-09 RU RU2006120491/15A patent/RU2006120491A/en not_active Application Discontinuation
- 2004-11-09 EP EP04810676A patent/EP1689352A2/en not_active Withdrawn
- 2004-11-09 KR KR1020067010335A patent/KR20060118514A/en not_active Application Discontinuation
- 2004-11-09 AU AU2004289311A patent/AU2004289311A1/en not_active Abandoned
- 2004-11-09 JP JP2006539813A patent/JP2007524657A/en active Pending
- 2004-11-09 WO PCT/US2004/037527 patent/WO2005046607A2/en active Application Filing
- 2004-11-09 BR BRPI0416390-7A patent/BRPI0416390A/en not_active Application Discontinuation
- 2004-11-09 CA CA002545423A patent/CA2545423A1/en not_active Abandoned
- 2004-11-12 AR ARP040104188A patent/AR046841A1/en unknown
-
2006
- 2006-05-11 IL IL175611A patent/IL175611A0/en unknown
- 2006-05-23 NO NO20062358A patent/NO20062358L/en not_active Application Discontinuation
- 2006-06-02 IS IS8496A patent/IS8496A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005046607A2 (en) | 2005-05-26 |
JP2007524657A (en) | 2007-08-30 |
TW200526777A (en) | 2005-08-16 |
RU2006120491A (en) | 2007-12-20 |
WO2005046607A3 (en) | 2012-12-20 |
KR20060118514A (en) | 2006-11-23 |
EP1689352A2 (en) | 2006-08-16 |
IS8496A (en) | 2006-06-02 |
CA2545423A1 (en) | 2005-05-26 |
AR046841A1 (en) | 2005-12-28 |
AU2004289311A1 (en) | 2005-05-26 |
IL175611A0 (en) | 2008-04-13 |
BRPI0416390A (en) | 2007-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202192738A1 (en) | TRICYCLIC COMPOUNDS PROVIDING DESTRUCTION OF IKAROS PROTEIN AND AIOLOS PROTEIN | |
EA201792191A1 (en) | FGFR / PD-1 COMBINED THERAPY FOR THE TREATMENT OF MALIGNANT TUMOR | |
DK1468014T3 (en) | Compositions and Methods for WT1-Specific Immunotherapy | |
NO20062885L (en) | Therapeutic anti-IGFR1 antibody combinations | |
NO2017019I1 (en) | Diarylhydantoin compound, pharmaceutical composition and use thereof | |
NO20070782L (en) | Tetrapeptidanaloger. | |
NO20055894L (en) | Methods and compositions for the treatment of amyloid-related diseases | |
NO20072179L (en) | Combination of an SRC kinase inhibitor and a. BCR-ABL inhibitor for the treatment of proliferative diseases | |
NO20073211L (en) | Tibulin-binding anti-cancer drugs and their promedics | |
NO20093060L (en) | Spirocyclic cyclohexane derivatives | |
NO20055832L (en) | Preparation and use of arylalkyl acid derivatives for the treatment of obesity | |
EA200901313A1 (en) | BLUTON TYROSINKINASE INHIBITORS | |
MY151032A (en) | Treatment of tnf? related disorders | |
DE602005014127D1 (en) | MEDICAL DEVICE AND MANUFACTURING METHOD THEREFOR | |
DE60319158D1 (en) | PYRAZOLOISOQUINOLINE DERIVATIVES AS KINASE INHIBITORS | |
CY1109551T1 (en) | PROTECTIVE SUSPENSIONS AND METHODS OF USING THESE | |
NO20055838L (en) | Active variants of IL-18 binding protein and medical applications thereof | |
NO20092658L (en) | New compounds | |
NO20060392L (en) | Combination of SRC kinase inhibitors chemotherapeutic agents for the treatment of proliferative diseases | |
NO20071585L (en) | New use of peptide compounds for the treatment of bone pain, chemotherapy and nucleoside induced pain | |
NO20055173L (en) | Pharmaceutical combination combination comprising modafinil and another drug | |
DK1325011T3 (en) | Methods and Compounds for the Treatment of Proliferative Diseases | |
NO20082425L (en) | Formulations comprising jorumycin, reni-eramycin, safracin or saframycin-related compounds for the treatment of proliferative diseases | |
MX2021007235A (en) | Tubulysins and protein-tubulysin conjugates. | |
NO20072285L (en) | S-mirtazapine for the treatment of hot flashes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |